Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Improved Replication-Competent Adenoviral Vectors

  • Read more about Improved Replication-Competent Adenoviral Vectors
US Application 60/629,722
Filed on 2004-11-18

Generation Of Plasmids With The Prophage Lamba Immunity Region, PL Promoter, And Red Genes For Transfer To Other Gram Negative Bacteria For The Purpose Of Recombineering In Those Organisms

  • Read more about Generation Of Plasmids With The Prophage Lamba Immunity Region, PL Promoter, And Red Genes For Transfer To Other Gram Negative Bacteria For The Purpose Of Recombineering In Those Organisms
US Application 60/653,259
Filed on 2005-02-14

Plasmids for Homologous Recombination and Methods of Use

  • Read more about Plasmids for Homologous Recombination and Methods of Use
US Application 60/573,504
Filed on 2004-05-21

Nitric Oxide Releasing Diazeniumdiolated Derivatives Of Acrylonitrile-containing Polymers

  • Read more about Nitric Oxide Releasing Diazeniumdiolated Derivatives Of Acrylonitrile-containing Polymers
US Application 60/613,257
Filed on 2004-09-27

Tricyclic Carboxamides as Inhibitors of the Hypoxic Signaling Pathway

  • Read more about Tricyclic Carboxamides as Inhibitors of the Hypoxic Signaling Pathway
US Application 60/570,615
Filed on 2004-05-12

Tricyclic Carboxamides as Inhibitors of the Hypoxic Signaling Pathway

  • Read more about Tricyclic Carboxamides as Inhibitors of the Hypoxic Signaling Pathway
US Application 60/618,279
Filed on 2004-10-12

METHODS FOR INHIBITING OR TREATING CANCER

  • Read more about METHODS FOR INHIBITING OR TREATING CANCER
US Application 60/588,918
Filed on 2004-07-16

Identification of proteins in a Genome

  • Read more about Identification of proteins in a Genome
US Application 60/628,948
Filed on 2004-11-19

IMMUNE MODULATORY ACTIVITY OF HUMAN RIBONUCLEASES

  • Read more about IMMUNE MODULATORY ACTIVITY OF HUMAN RIBONUCLEASES
US Application 60/393,110
Filed on 2002-07-03

Cytonectin, Cytonectin Gene and Cytonectin Inhibitors and Binding Ligands, and Their Use in the Diagnosis and Treatment of Disease

  • Read more about Cytonectin, Cytonectin Gene and Cytonectin Inhibitors and Binding Ligands, and Their Use in the Diagnosis and Treatment of Disease
US Application 60/578,068
Filed on 2004-06-09

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 164
  • Page 165
  • Page 166
  • Page 167
  • Page 168
  • Page 169
  • Page 170
  • Page 171
  • Page 172
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health